KLK3 and Familial prostate cancer: KLK3 encodes the prostate specific antigen, a serum based tumour marker that this widely used in the diagnosis and risk stratification of prostate cancer, as well as monitoring response to treatment, where higher serum levels of PSA are commonly associated with aggressive disease and poorer outcome.